Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submissions for lenacapavir—the company’s twice-yearly ...

Intrommune Therapeutics, Inc. is excited to announce the publication of a its Phase 1 OMEGA (Oral Mucosal Escalation Goal Assessment) study evaluating the safety, tolerability, and adherence of a ...

ImmunityBio (IBRX) announced the U.S. Food and Drug Administration FDA has authorized an expanded access program EAP that will bring a vital ...

Nanoparticle characterization is vital for mRNA vaccine efficacy, ensuring safety and regulatory compliance in the ...

The companies most frequently linked to cases were the PIF (10 cases), Meta (8 cases), Uber including Uber Eats (6), Carrefour (5), and Deliveroo, Giorgio Armani, John Lewis Partnership, Marks & ...

Light AI Inc. ("Light AI" or the "Company") (CBOE CA: ALGO) (FSE: 0HC) a global healthcare technology company focused on developing artificial intelligence health diagnostic and wellness solutions, ...

Millar, a global leader in MEMS sensor technology, proudly announces the successful integration of Sentron, a Millar Company, ...

(Reuters) - Chipotle Mexican Grill will hire 20,000 additional employees for the period of March to May as the company gears ...

DelveInsight's Transmucosal Drugs Market Insights report provides the current and forecast market analysis, individual ...

A couple's harrowing journey from cartel violence to an uncertain future in California reveals the human cost of immigration ...

At this time, I would like to welcome everyone to the Karyopharm Therapeutics fourth quarter and full year 2024 financial results conference call. There will be a question-and-answer session to follow ...

The increasing prevalence of chronic conditions like cardiovascular disease is driving the demand for transmucosal drugs. Key factors contributing to the transmucosal drugs market's growth from ...